Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Rapid Dose Therapeutics Corp (DOSE.CN)

Rapid Dose Therapeutics Corp (DOSE.CN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 28,515
  • Shares Outstanding, K 77,067
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta -7.60
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 33.47
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.24
  • Most Recent Earnings -0.04 on 11/30/19
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.180 +105.56%
on 07/06/20
0.380 -2.63%
on 08/05/20
+0.160 (+76.19%)
since 07/03/20
3-Month
0.180 +105.56%
on 07/06/20
0.380 -2.63%
on 08/05/20
+0.120 (+48.00%)
since 05/05/20
52-Week
0.180 +105.56%
on 07/06/20
0.820 -54.88%
on 08/23/19
-0.370 (-50.00%)
since 08/02/19

Most Recent Stories

More News
Rapid Dose Therapeutics Announces Delay in Quarterly Filings Under COVID-19 Duress

Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announces that due to circumstances created by the COVID-19 pandemic, the Ontario Securities Commission and other members of the Canadian...

DOSE.CN : 0.370 (+12.12%)
Rapid Dose Therapeutics and McMaster University Initiate QuickStrip(TM) COVID-19 Vaccine Research With Immediate Impact

Rapid Dose Therapeutics Corp. ("RDT" or the "Company") (CSE: DOSE), a Canadian Life Sciences company focused on innovative drug and active ingredient delivery solutions, is pleased to announce it has begun...

DOSE.CN : 0.370 (+12.12%)
Rapid Dose Therapeutics Announces Delay in Annual Filings Under COVID-19 Duress

Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announces that due to circumstances created by the COVID-19 pandemic, the Ontario Securities Commission and other members of the Canadian...

DOSE.CN : 0.370 (+12.12%)
Rapid Dose Therapeutics Files a Patent to Synthesize THC From CBD Using a Selective Delta 8 or Delta 9 Conversion Process

Rapid Dose Therapeutics Corp. ("RDT" or the "Company") (CSE: DOSE), a Canadian Life Sciences company focused on innovative drug and active ingredient delivery solutions, is pleased to announce it has filed...

DOSE.CN : 0.370 (+12.12%)
RAPID DOSE THERAPEUTICS Signs agreement with Leede Jones Gable to provide Financial Advisory Services and Announces Change to its Board of Directors

Rapid Dose Therapeutics Corp. ("RDT" or the "Company") (CSE: DOSE), a Canadian Life Sciences company focused on innovative drug and active ingredient delivery solutions, is pleased to announce it has signed...

DOSE.CN : 0.370 (+12.12%)
RAPID DOSE THERAPEUTICS DONATES QUICKSTRIP(TM) VITAMIN B12 NUTRACEUTICAL PRODUCT TO COMMUNITY

Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Corporation") in response to the COVID pandemic, recently made a donation to the Burlington Foodbank contributing over 16,000 QuickStrip(TM) Vitamin...

DOSE.CN : 0.370 (+12.12%)
RAPID DOSE THERAPEUTICS ANNOUNCES SHIPMENT OF QUICKSTRIP(TM) NUTRACEUTICAL PRODUCTS

Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Corporation") is pleased to announce that RDT has completed its first shipment of QuickStrip(TM) nutraceutical products to Peter Pan Brands. The...

DOSE.CN : 0.370 (+12.12%)
IIROC Trade Resumption - DOSE

Trading resumes in:

DOSE.CN : 0.370 (+12.12%)
IIROC Trading Halt - DOSE

The following issues have been halted by IIROC:

DOSE.CN : 0.370 (+12.12%)
Rapid Dose Therapeutics Announces Investment Agreement With Institutional Investor

Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Corporation") today announced that it has entered into an agreement for a drawdown equity financing facility (the "Investment Agreement") with a...

DOSE.CN : 0.370 (+12.12%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Average short term outlook on maintaining the current direction.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Key Turning Points

2nd Resistance Point 0.383
1st Resistance Point 0.377
Last Price 0.370
1st Support Level 0.367
2nd Support Level 0.363

See More

52-Week High 0.820
Fibonacci 61.8% 0.576
Fibonacci 50% 0.500
Fibonacci 38.2% 0.424
Last Price 0.370
52-Week Low 0.180

See More

Business Summary

Rapid Dose Therapeutics Corp is a bio-technology company which, through its subsidiaries, provides proprietary enhanced drug delivery technologies designed to improve patient outcomes. The company through its subsidiary, owns a proprietary oral fast-dissolving drug delivery system, QuickStrip, which...

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar